This course type is lecture

Translating and Commercialising Genomic Research

07 - 09 December 2016Wellcome Genome Campus, Hinxton, UK
Deadlines (at 23:59 UTC):
  • Bursary Deadline Closed
  • Application Deadline Closed

  • Summary

    This new course aims to develop professional skills to help translate
    genomics research into healthcare products and services that ultimately
    benefit society.

    The rapid progress in genomics research over the past decade has brought
    great potential for public benefit. The next generation sequencing era is
    helping to develop diagnostic products, new approaches to drug discovery
    and development, and stratified medicine approaches to therapy. However,
    translation paths for technologies are still emerging. This course will
    focus on the specific knowledge required to translate and commercialise
    genomics research, for example the type of IP (e.g. database rights,
    software copyright vs more ’classical‘ patent rights), the history and
    culture landscape (e.g. navigating the complexities of open source
    licenses for the benefit of innovation), and the use and sharing of human
    genetic data, including ethical and policy considerations.

    The programme will be delivered by entrepreneurs, investors, industry
    users and technology transfer professionals who will discuss options
    through real life examples of the exploitation of databases,
    bioinformatics tools, biomarkers, genetic signatures or gene panels. The
    content will be delivered through lectures, discussions, case studies and
    group work. Together with senior investment professionals and
    entrepreneurs, course participants will examine and discuss real life
    business models.

    This course is designed for a range of professionals involved in
    exploitation of technologies, such as business development professionals,
    business analysts in the investment community, innovation funders or
    senior researchers actively involved in translation. As the course has a
    specific emphasis on highlighting business models and developing spin
    outs as an exploitation route, it will also be useful to aspiring
    entrepreneurs. Through this course we aim to help build a community of
    professionals working in the translation of genomics and informatics.

    Learning outcomes
    After attending this course, participants will be able to:

    • Plan an exploitation strategy that considers the impact on future research and on clinical adoption.
    • Navigate the regulatory environment that frames the implementation of genomics tools and diagnostics in the clinic.
    • Work within the ‘culture landscape’ of software licenses and innovation framework.
    • Exploit a variety of business models around biodata, bioinformatics or genomic information.
  • Programme

    The course will start at approximately 9.30 on Wednesday, 7 December and
    close at approximately 16.00 on Friday, 9 December 2016.

    The programme will be delivered by entrepreneurs, investors, industry
    users and technology transfer professionals. The content will be
    delivered through lectures, discussions, case studies and group work.
    Each session will start with an introduction to the the session followed
    by discussions of real life examples, relevent case studies and group
    work. We aim to provide an immersive and engaging experience for
    participants.

    Sessions will include:

    • Commercial opportunities arising from data aggregation
    • Exploiting bioinformatics tools
    • Externalising bioinformatics pipelines
    • Translating biomarkers, genetic signatures or gene panels

    This is a residential course. All participants are requested to stay
    onsite for the full duration to benefit fully from discussions and
    interactions with the faculty and other students.

  • Instructors / Speakers

    Scientific programme committee
    Emmanuelle Astoul Wellcome Trust Sanger Institute, UK
    Fiona Nielsen
    Repositive/DNAdigest, UK
    Abel Ureta-Vidal Eagle Genomics, UK
    Ross Rounsevell Wellcome Trust Sanger
    Institute, UK

    Keynote speaker
    Phil Stephens Foundation Medicine, USA

    Tutors
    Melina Cimler Adaptive Biotechnologies, USA

    Patrick Farrant Taylor Vinters, UK
    Davina Gale Inivata, UK
    Emily Hayes Mewburn Ellis, UK 

    Angus Lauder Cancer Research Technology, UK

    Wouter Meuleman Illumina Ventures, USA
    Simon Portman Marks and Clerk Solicitors,
    UK
    David Rainford Taylor Vinters, UK
    Sobia Raza PHG Foundation, UK 
    Frank Schacherer Qiagen, Germany
    Simon Turner Kuma Partners, France
    Tom
    Weaver
    Congenica, UK

    Event organiser
    Jane Sullivan Wellcome Genome Campus, UK

  • How to Apply

    Fees

    Academic Registration with Single Accommodation  £394.00
    Commercial Registration with Single Accommodation £494.00

    The fees include accommodation, meals and lectures for the duration of
    the course. The fee will be requested once acceptance is confirmed.

    Accommodation
    This is a residential course. All participants will stay at The Wellcome
    Genome Campus Conference Centre, Hinxton, Cambridge, for the nights
    of 7 and 8 December 2016. 

    If you wish to book onsite accommodation either side of the course
    dates, please contact the Conference
    Centre
    directly.

    Applications
    Application deadline: Closed

    Places on this course are limited. Applicants should be professionals
    involved in exploitation of technologies (such as knowledge
    transfer/technology transfer professionals), business analysts in the
    investment community, innovation funders, senior researchers actively
    involved in translation, or aspiring entrepreneurs.

    Please note: Applicants should be familiar with the
    basics of technology transfer and IP exploitation. Incomplete
    applications will not be considered. 

    The selection process will take place in early November 2016.

    Travel visas
    Please contact the event organiser if you require a letter to support a
    travel visa application. Note that letters will be provided to confirmed
    attendees on request.

    Non-European Economic Area or Swiss nationals may be required to have a
    visa to enter the UK.
    Early application is strongly advised, as this process can take 6-8 weeks
    or longer.

    Please visit the following websites for further information:
    UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/

    Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/

  • Bursaries

    A limited number of registration bursaries are available to attend this
    course (up to 50% of the fee).
    The following documents will need to be provided:

    • CV
    • Covering letter

    To apply, please contact the event organiser.

    Bursary deadline: Closed

  • Sponsors

    We thank the following organisations for their support.